Literature DB >> 21849686

Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.

Rosana H V Pereira1, Ana Paula Carvalho-Assef, Rodolpho M Albano, Tania W Folescu, Marcia C M F Jones, Robson S Leão, Elizabeth A Marques.   

Abstract

We investigated the possibility of cross-infection among cystic fibrosis patients in two Brazilian reference centers. Achromobacter xylosoxidans isolates (n = 122) were recovered over a 5-year period from 39 patients. Isolates were genetically heterogeneous, but one genotype was present in 56% of the patients, suggesting that cross-infection may have occurred.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21849686      PMCID： PMC3187335          DOI： 10.1128/JCM.05283-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Direct automated sequencing of 16S rDNA amplified by polymerase chain reaction from bacterial cultures without DNA purification.

Authors:  A Hiraishi
Journal:  Lett Appl Microbiol       Date:  1992-11       Impact factor: 2.858

2.  Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.

Authors:  Frans De Baets; Petra Schelstraete; Sabine Van Daele; Filomeen Haerynck; Mario Vaneechoutte
Journal:  J Cyst Fibros       Date:  2006-06-21       Impact factor: 5.482

3.  Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis.

Authors:  H Peltroche-Llacshuanga; H Peltroche-Llacsahuanga; H Kentrup; G Haase
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

4.  Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.

Authors:  Sabine Van Daele; Rita Verhelst; Geert Claeys; Gerda Verschraegen; Hilde Franckx; Leen Van Simaey; Catharine de Ganck; Frans De Baets; Mario Vaneechoutte
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.

Authors:  Julia Emerson; Sharon McNamara; Anne Marie Buccat; Kelly Worrell; Jane L Burns
Journal:  Pediatr Pulmonol       Date:  2010-04

6.  Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.

Authors:  Lixia Liu; Tom Coenye; Jane L Burns; Paul W Whitby; Terrence L Stull; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  First report of Paenibacillus cineris from a patient with cystic fibrosis.

Authors:  Robson Souza Leão; Rosana Helena Vicente Pereira; Alex Guerra Ferreira; Adma Nascimento Lima; Rodolpho Mattos Albano; Elizabeth Andrade Marques
Journal:  Diagn Microbiol Infect Dis       Date:  2009-08-25       Impact factor: 2.803

8.  Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone.

Authors:  M Kanellopoulou; S Pournaras; H Iglezos; N Skarmoutsou; E Papafrangas; A N Maniatis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

9.  Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.

Authors:  Annarita Magni; Maria Trancassini; Paola Varesi; Valerio Iebba; Anna Curci; Claudia Pecoraro; Giuseppe Cimino; Serena Schippa; Serena Quattrucci
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

10.  Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.

Authors:  A Lambiase; M R Catania; M Del Pezzo; F Rossano; V Terlizzi; A Sepe; V Raia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-31       Impact factor: 3.267
View more
  19 in total

1.  Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.

Authors:  B D Edwards; J Greysson-Wong; R Somayaji; B Waddell; F J Whelan; D G Storey; H R Rabin; M G Surette; M D Parkins
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  Impact of High Diversity of Achromobacter Populations within Cystic Fibrosis Sputum Samples on Antimicrobial Susceptibility Testing.

Authors:  Chloé Dupont; Estelle Jumas-Bilak; Anne-Laure Michon; Raphaël Chiron; Hélène Marchandin
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

3.  Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.

Authors:  Winnie Ridderberg; Mikala Wang; Niels Nørskov-Lauritsen
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

4.  Distribution of Achromobacter Species in 12 French Cystic Fibrosis Centers in 2020 by a Retrospective MALDI-TOF MS Spectrum Analysis.

Authors:  Thomas Garrigos; Manon Dollat; Arnaud Magallon; Anaïs Folletet; Julien Bador; Maryam Abid; Marlène Amara; Clémence Beauruelle; Olivier Belmonte; Pierre Boyer; Emilie Cardot-Martin; Anne-Gaëlle Cauchie; Sylvie Colin de Verdière; Claire Daurel; Cécile Gaudru; Farida Hamdad; Geneviève Héry-Arnaud; Baptiste Hoellinger; Claudie Lamoureux; Marie-Frédérique Lartigue; Damasie Malandain; Océane Marchand; Caroline Piau; Sandrine Picot; Hélène Revillet; Zeina Sabouni; Catherine Neuwirth; Lucie Amoureux
Journal:  J Clin Microbiol       Date:  2022-05-05       Impact factor: 11.677

5.  Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.

Authors:  Laura Barrado; Patricia Brañas; M Ángeles Orellana; M Teresa Martínez; Gloria García; Joaquín R Otero; Fernando Chaves
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

6.  Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Elenice R A Rodrigues; Alex G Ferreira; Robson S Leão; Cassiana C F Leite; Ana Paula Carvalho-Assef; Rodolpho M Albano; Elizabeth A Marques
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

7.  Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.

Authors:  Lucie Amoureux; Julien Bador; Sakina Fardeheb; Cédric Mabille; Charlyne Couchot; Clémence Massip; Anne-Lise Salignon; Guillaume Berlie; Véronique Varin; Catherine Neuwirth
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

8.  Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis.

Authors:  R H V Pereira; R S Leão; A P Carvalho-Assef; R M Albano; E R A Rodrigues; M C Firmida; T W Folescu; M C Plotkowski; V G Bernardo; E A Marques
Journal:  Epidemiol Infect       Date:  2016-11-22       Impact factor: 4.434

9.  Hospital Acquired Pneumonia Due to Achromobacter spp. in a Geriatric Ward in China: Clinical Characteristic, Genome Variability, Biofilm Production, Antibiotic Resistance and Integron in Isolated Strains.

Authors:  Chao Liu; Fei Pan; Jun Guo; Weifeng Yan; Yi Jin; Changting Liu; Long Qin; Xiangqun Fang
Journal:  Front Microbiol       Date:  2016-05-09       Impact factor: 5.640

10.  Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains.

Authors:  Maria Trancassini; Valerio Iebba; Nicoletta Citerà; Vanessa Tuccio; Annarita Magni; Paola Varesi; Riccardo V De Biase; Valentina Totino; Floriana Santangelo; Antonella Gagliardi; Serena Schippa
Journal:  Front Microbiol       Date:  2014-04-03       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.